PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 183 filers reported holding PORTOLA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $118,000 | +151.1% | 6,565 | 0.0% | 0.01% | +100.0% |
| Q1 2020 | $47,000 | -70.1% | 6,565 | 0.0% | 0.00% | -57.1% |
| Q4 2019 | $157,000 | -6.0% | 6,565 | +5.6% | 0.01% | -12.5% |
| Q3 2019 | $167,000 | +13.6% | 6,214 | +14.5% | 0.01% | +14.3% |
| Q2 2019 | $147,000 | -21.8% | 5,426 | 0.0% | 0.01% | -22.2% |
| Q1 2019 | $188,000 | +77.4% | 5,426 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $106,000 | -26.4% | 5,426 | 0.0% | 0.01% | -14.3% |
| Q3 2018 | $144,000 | -26.9% | 5,426 | +4.1% | 0.01% | -22.2% |
| Q2 2018 | $197,000 | +27.9% | 5,211 | +10.8% | 0.01% | +28.6% |
| Q1 2018 | $154,000 | -32.8% | 4,704 | 0.0% | 0.01% | -30.0% |
| Q4 2017 | $229,000 | -14.9% | 4,704 | +10.6% | 0.01% | -23.1% |
| Q3 2017 | $269,000 | +12.6% | 4,254 | 0.0% | 0.01% | +8.3% |
| Q2 2017 | $239,000 | +43.1% | 4,254 | 0.0% | 0.01% | +50.0% |
| Q1 2017 | $167,000 | – | 4,254 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
| PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
| Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
| Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
| HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
| Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
| ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
| Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |